Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 244 articles:
HTML format



Single Articles


    November 2022
  1. TADESSE BT, Bravo L, Marks F, Aziz AB, et al
    Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines.
    Clin Infect Dis. 2022 Nov 26:ciac914. doi: 10.1093.
    PubMed     Abstract available


  2. MARTIN C, Dauby N
    Guiding yellow fever vaccination strategy worldwide: booster = better?
    Clin Infect Dis. 2022 Nov 16. pii: 6830230. doi: 10.1093.
    PubMed    


  3. SHAH MM, Spencer BR, Feldstein LR, Haynes JM, et al
    Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
    Clin Infect Dis. 2022 Nov 14. pii: 6825618. doi: 10.1093.
    PubMed     Abstract available


  4. BARDA N, Canetti M, Gilboa M, Asraf K, et al
    The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 Nov 11. pii: 6821340. doi: 10.1093.
    PubMed     Abstract available


  5. OTERO S, Miller ES, Sunderraj A, Shanes ED, et al
    Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy.
    Clin Infect Dis. 2022 Nov 9. pii: 6812657. doi: 10.1093.
    PubMed     Abstract available


  6. SIEGHART D, Hana CA, Haslacher H, Perkmann T, et al
    MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY.
    Clin Infect Dis. 2022 Nov 4. pii: 6795267. doi: 10.1093.
    PubMed     Abstract available


  7. TENFORDE MW, Patel MM, Lewis NM, Adams K, et al
    Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness, United States, 2022.
    Clin Infect Dis. 2022 Nov 3. pii: 6795261. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  8. BETTINGER JA, Irvine MA, Shulha HP, Valiquette L, et al
    Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network.
    Clin Infect Dis. 2022 Oct 31. pii: 6780916. doi: 10.1093.
    PubMed     Abstract available


  9. ASARE K, Andine T, Naicker N, Dorward J, et al
    Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial.
    Clin Infect Dis. 2022 Oct 15. pii: 6761890. doi: 10.1093.
    PubMed     Abstract available


  10. MALOSH RE, McGovern I, Monto AS
    Influenza During the 2010-2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions.
    Clin Infect Dis. 2022 Oct 11. pii: 6758391. doi: 10.1093.
    PubMed     Abstract available


  11. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
    Clin Infect Dis. 2022 Oct 10. pii: 6754597. doi: 10.1093.
    PubMed     Abstract available


  12. BISWAL S, Patel SS, Rauscher M
    Safety of Dengue Vaccine?
    Clin Infect Dis. 2022 Oct 5. pii: 6748245. doi: 10.1093.
    PubMed    


  13. FIDLER S, Fox J, Tipoe T, Longet S, et al
    Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
    Clin Infect Dis. 2022 Oct 5. pii: 6748267. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  14. ISLAM MT, Date K, Khan AI, Bhuiyan TR, et al
    Co-administration of Oral Cholera Vaccine with Oral Polio Vaccine among Bangladeshi Young Children: A Randomized Controlled Open Label Trial to Assess Interference.
    Clin Infect Dis. 2022 Sep 22. pii: 6711550. doi: 10.1093.
    PubMed     Abstract available


  15. FLOREA A, Sy LS, Qian L, Ackerson BK, et al
    Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults.
    Clin Infect Dis. 2022 Sep 22. pii: 6711079. doi: 10.1093.
    PubMed     Abstract available


  16. SIANGPHOE U, Baden LR, El Sahly HM, Essink B, et al
    Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials.
    Clin Infect Dis. 2022 Sep 20. pii: 6708263. doi: 10.1093.
    PubMed     Abstract available


  17. ONO S, Michihata N, Yamana H, Uemura K, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 booster dose after BNT162b2 primary vaccination against the Omicron variants: A retrospective cohort study using large-scale population-based registries in Japan.
    Clin Infect Dis. 2022 Sep 18. pii: 6696997. doi: 10.1093.
    PubMed     Abstract available


  18. BOULWARE DR, Murray TA, Proper JL, Tignanelli CJ, et al
    Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.
    Clin Infect Dis. 2022 Sep 17. pii: 6702474. doi: 10.1093.
    PubMed     Abstract available


  19. HSU CK, Lai CC
    The confounding effect of vaccine status.
    Clin Infect Dis. 2022 Sep 16. pii: 6701809. doi: 10.1093.
    PubMed    


  20. TURNER P, Sa-Leao R, Greenhill A, Leach A, et al
    World Health Organization (WHO) Standard Methods for Pneumococcal Carriage Studies.
    Clin Infect Dis. 2022;75:924-925.
    PubMed    


  21. MAGNUS MC, Haberg SE, Carlsen EO, Kwong JC, et al
    Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Sep 8. pii: 6693880. doi: 10.1093.
    PubMed     Abstract available


  22. NIKAS A, Ahmed H, Zarnitsyna VI
    Estimating Waning of Vaccine Effectiveness: a Simulation Study.
    Clin Infect Dis. 2022 Sep 3. pii: 6691361. doi: 10.1093.
    PubMed     Abstract available


  23. VAN DIJCK C, Hens N, Kenyon C, Tsoumanis A, et al
    The roles of unrecognized monkeypox cases, contact isolation and vaccination in determining epidemic size in Belgium. A modelling study.
    Clin Infect Dis. 2022 Sep 2. pii: 6686539. doi: 10.1093.
    PubMed     Abstract available


  24. DE SILVA A
    Safety of Dengue Vaccine?
    Clin Infect Dis. 2022 Sep 1. pii: 6681127. doi: 10.1093.
    PubMed    


    August 2022
  25. MATHIS AD, Clemmons NS, Redd SB, Pham H, et al
    Maintenance of Measles Elimination Status in the United States for 20 Years Despite Increasing Challenges.
    Clin Infect Dis. 2022;75:416-424.
    PubMed     Abstract available


  26. ORIJE MRP, Garcia-Fogeda I, Van Dyck W, Corbiere V, et al
    Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
    Clin Infect Dis. 2022;75:442-452.
    PubMed     Abstract available


  27. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    PubMed    


  28. GAGLANI M, Kim SS, Naleway AL, Levine MZ, et al
    Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
    Clin Infect Dis. 2022 Aug 29. pii: 6678123. doi: 10.1093.
    PubMed     Abstract available


  29. AMIN AB, Tate JE, Waller LA, Lash TL, et al
    Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of Phase II and III trial data.
    Clin Infect Dis. 2022 Aug 29. pii: 6678127. doi: 10.1093.
    PubMed     Abstract available


  30. BANERJEE E, Paul P, Griffith J, Laine E, et al
    Impact of Isolation and Exclusion as a Public Health Strategy to Contain Measles Virus Transmission During a Measles Outbreak.
    Clin Infect Dis. 2022;75:152-154.
    PubMed     Abstract available


  31. ANDREJKO K, Ratnasiri B, Lewnard JA
    Association of Pneumococcal Serotype With Susceptibility to Antimicrobial Drugs: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2022;75:131-140.
    PubMed     Abstract available


  32. GANATRA S, Dani SS, Ahmad J, Kumar A, et al
    Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19.
    Clin Infect Dis. 2022 Aug 20. pii: 6672670. doi: 10.1093.
    PubMed     Abstract available


  33. NASREEN S, Febriani Y, Velasquez Garcia HA, Zhang G, et al
    Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study.
    Clin Infect Dis. 2022 Aug 17. pii: 6668859. doi: 10.1093.
    PubMed     Abstract available


  34. KARABA AH, Zhou W, Li S, Aytenfisu TY, et al
    Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2022 Aug 12. pii: 6663288. doi: 10.1093.
    PubMed     Abstract available


  35. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    PubMed     Abstract available


  36. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  37. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    PubMed     Abstract available


  38. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    PubMed     Abstract available


  39. SAHNI LC, Naioti EA, Olson SM, Campbell AP, et al
    Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.
    Clin Infect Dis. 2022 Jul 22. pii: 6648556. doi: 10.1093.
    PubMed     Abstract available


  40. KLING K, Domingo C, Bogdan C, Duffy S, et al
    Duration of protection after vaccination against yellow fever - systematic review and meta-analysis.
    Clin Infect Dis. 2022 Jul 20. pii: 6646957. doi: 10.1093.
    PubMed     Abstract available


  41. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    PubMed     Abstract available


  42. PARAMESWARAN GI, Wattengel BA, Chua HC, Swiderek J, et al
    Increased Stroke Risk Following Herpes Zoster Infection and Protection with Zoster Vaccine.
    Clin Infect Dis. 2022 Jul 7. pii: 6633277. doi: 10.1093.
    PubMed     Abstract available


  43. SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
    Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
    PubMed     Abstract available


  44. TURNER AN, Carter AM, Tzeng YL, Stephens DS, et al
    Infection With the US Neisseria meningitidis Urethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea.
    Clin Infect Dis. 2022;74:2159-2165.
    PubMed     Abstract available


  45. GRANT LR, Slack MPE, Theilacker C, Vojicic J, et al
    Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children from High-Income Countries and the Impact of Pediatric Pneumococcal Vaccination.
    Clin Infect Dis. 2022 Jul 5. pii: 6629370. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  46. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    PubMed     Abstract available


  47. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    PubMed     Abstract available


  48. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    PubMed     Abstract available


  49. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    PubMed     Abstract available


  50. IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
    SARS-CoV-2 in Africa: current considerations and future projections.
    Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
    PubMed     Abstract available


  51. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    PubMed     Abstract available


  52. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    PubMed     Abstract available


  53. PLOTKIN SA
    Why We Need Precision Vaccinology.
    Clin Infect Dis. 2022 Jun 23. pii: 6615391. doi: 10.1093.
    PubMed    


  54. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    PubMed     Abstract available


  55. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    PubMed     Abstract available


  56. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    PubMed     Abstract available


  57. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    PubMed     Abstract available


  58. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    PubMed     Abstract available


  59. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    PubMed     Abstract available


  60. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    PubMed     Abstract available


  61. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    PubMed     Abstract available


  62. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    PubMed     Abstract available


  63. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    PubMed     Abstract available


  64. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    PubMed     Abstract available


  65. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    PubMed     Abstract available


  66. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    PubMed     Abstract available


  67. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    PubMed     Abstract available


  68. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    PubMed     Abstract available


  69. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    PubMed     Abstract available


  70. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    PubMed     Abstract available


  71. NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
    Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
    Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
    PubMed     Abstract available


  72. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    PubMed     Abstract available


  73. BRUXVOORT KJ, Lewnard JA, Chen LH, Tseng HF, et al
    Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California.
    Clin Infect Dis. 2022 Jun 1. pii: 6596517. doi: 10.1093.
    PubMed     Abstract available


  74. HAVERS FP, Skoff TH, Rench MA, Epperson M, et al
    Maternal Tdap Vaccination during Pregnancy: Impact on Infant Anti-pertussis Antibody Concentrations by Maternal Pertussis Priming Series.
    Clin Infect Dis. 2022 Jun 1. pii: 6596516. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  75. ISHOLA D
    Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
    Clin Infect Dis. 2022 May 30. pii: 6595436. doi: 10.1093.
    PubMed     Abstract available


  76. ANGLEMYER A, McNeill A, DuBray K, Sonder GJB, et al
    Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand.
    Clin Infect Dis. 2022;74:1859-1861.
    PubMed     Abstract available


  77. MEIRING S, Tempia S, Dominic EM, de Gouveia L, et al
    Excess Invasive Meningococcal Disease Associated With Seasonal Influenza, South Africa, 2003-2018.
    Clin Infect Dis. 2022;74:1729-1735.
    PubMed     Abstract available


  78. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    PubMed     Abstract available


  79. PATEL SS, Rauscher M, Kudela M, Pang H, et al
    Clinical Safety Experience of TAK-003 for Dengue Fever: a new Tetravalent Live Attenuated Vaccine Candidate.
    Clin Infect Dis. 2022 May 26. pii: 6593313. doi: 10.1093.
    PubMed     Abstract available


  80. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    PubMed     Abstract available


  81. PETROS BA, Turcinovic J, Welch NL, White LF, et al
    Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
    Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
    PubMed     Abstract available


  82. GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
    Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
    Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
    PubMed     Abstract available


  83. EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
    Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
    Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
    PubMed     Abstract available


  84. CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
    Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
    Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
    PubMed     Abstract available


  85. LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
    How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
    Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
    PubMed     Abstract available


  86. EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
    COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
    Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
    PubMed     Abstract available


  87. LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
    PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
    Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
    PubMed     Abstract available


  88. SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
    Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
    Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
    PubMed     Abstract available


  89. ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
    Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
    Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
    PubMed     Abstract available


  90. LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
    Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
    Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
    PubMed     Abstract available


  91. TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
    Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
    Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
    PubMed     Abstract available


  92. MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
    A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
    Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
    PubMed     Abstract available


  93. WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
    Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
    PubMed     Abstract available


  94. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    PubMed     Abstract available


  95. BARI A, Heymann M, Cohen RJ, Zhao R, et al
    Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
    Clin Infect Dis. 2022;74.
    PubMed     Abstract available


  96. POH XY, Tan CW, Lee IR, Chavatte JM, et al
    Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
    Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
    PubMed     Abstract available


  97. CONTI MG, Terreri S, Terrin G, Natale F, et al
    SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
    Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
    PubMed     Abstract available


  98. SPARKE M, Levy O
    Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
    PubMed     Abstract available


  99. ZURCHER K, Abela IA, Stange M, Dupont C, et al
    Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
    Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
    PubMed     Abstract available


  100. DOWLING DJ, Levy O
    A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
    PubMed     Abstract available


  101. BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
    Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
    Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
    PubMed     Abstract available


  102. BEN-SHIMOL S, Regev-Yochay G, Givon-Lavi N, van der Beek BA, et al
    Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance.
    Clin Infect Dis. 2022;74:1639-1649.
    PubMed     Abstract available


    April 2022
  103. CHOW EPF, Fairley CK, Zou H, Wigan R, et al
    Correction to: Human Papillomavirus Antibody Levels Following Vaccination or Natural Infection Among Young Men Who Have Sex With Men.
    Clin Infect Dis. 2022 Apr 27. pii: 6574995. doi: 10.1093.
    PubMed    


  104. BUSKERMOLEN M, Molthof I, Voeten HA, van Twillert J, et al
    Vaccination did not prevent severe COVID in an outbreak among older residents of a nursing home, B.1.617.2 variant, July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574733. doi: 10.1093.
    PubMed    


  105. SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
    PubMed     Abstract available


  106. SHARMA A, Oda G, Holodniy M
    Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
    PubMed     Abstract available


  107. SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
    Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
    PubMed     Abstract available


  108. ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
    Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
    PubMed     Abstract available


  109. DAN J, da Silva Antunes R, Grifoni A, Weiskopf D, et al
    Observations and perspectives on adaptive immunity to SARS-CoV-2.
    Clin Infect Dis. 2022 Apr 20. pii: 6571103. doi: 10.1093.
    PubMed     Abstract available


  110. KIM J, Choe YJ, Jang EJ, Lim DS, et al
    Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
    Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
    PubMed    


  111. NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
    Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
    PubMed     Abstract available


  112. LEVY O, Angelidou A, Idoko O, Lewis NP, et al
    Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
    Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
    PubMed    


  113. WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
    Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
    Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
    PubMed     Abstract available


  114. SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
    Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
    Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
    PubMed     Abstract available


  115. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
    PubMed     Abstract available


  116. MOORE HC, Cannon JW, Kaslow DC, Lamagni T, et al
    A systematic framework for prioritising burden of disease data required for vaccine development and implementation: the case for group A streptococcal diseases.
    Clin Infect Dis. 2022 Apr 19. pii: 6570502. doi: 10.1093.
    PubMed     Abstract available


  117. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    PubMed     Abstract available


  118. DALE AP, Almendares O, Howard B, Burnett E, et al
    Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
    Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
    PubMed     Abstract available


  119. PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
    Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
    Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
    PubMed     Abstract available


  120. TADESSE BT, Khanam F, Ahmed F, Im J, et al
    Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
    Clin Infect Dis. 2022 Apr 12. pii: 6567455. doi: 10.1093.
    PubMed     Abstract available


  121. RZYMSKI P, Falfushynska H, Fal A
    Vaccination of Ukrainian Refugees: Need for Urgent Action.
    Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
    PubMed     Abstract available


  122. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
    Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
    PubMed     Abstract available


  123. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  124. DOLL MK, Pettigrew SM, Ma J, Verma A, et al
    Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
    PubMed     Abstract available


  125. NG OT, Koh V, Chiew CJ, Marimuthu K, et al
    Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
    Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
    PubMed     Abstract available


  126. GIMENEZ E, Albert E, Zulaica J, Torres I, et al
    SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
    Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
    PubMed     Abstract available


  127. GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
    Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
    Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
    PubMed     Abstract available


  128. RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
    SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
    Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
    PubMed     Abstract available


  129. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    PubMed     Abstract available


  130. MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
    Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
    Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
    PubMed     Abstract available


  131. POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
    Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
    Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
    PubMed     Abstract available


  132. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
    Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
    PubMed     Abstract available


  133. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    PubMed     Abstract available


  134. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    PubMed    


    February 2022
  135. BERENDSEN MLT, Silva I, Bale C, Nielsen S, et al
    The effect of a second dose of measles vaccine at 18 months of age on non-accidental deaths and hospital admissions in Guinea-Bissau: interim analysis of a randomized controlled trial.
    Clin Infect Dis. 2022 Feb 26. pii: 6537530. doi: 10.1093.
    PubMed     Abstract available


  136. HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
    Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
    Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
    PubMed     Abstract available


  137. LI C, Ye Z, Zhang AJ, Chan JF, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.
    Clin Infect Dis. 2022 Feb 18. pii: 6530400. doi: 10.1093.
    PubMed     Abstract available


  138. BECERRA-CULQUI TA, Getahun D, Chiu V, Sy LS, et al
    Prenatal influenza vaccination or influenza infection and autism spectrum disorder in offspring.
    Clin Infect Dis. 2022 Feb 17. pii: 6528744. doi: 10.1093.
    PubMed     Abstract available


  139. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels.
    Clin Infect Dis. 2022 Feb 16. pii: 6529520. doi: 10.1093.
    PubMed     Abstract available


  140. GAO DX, Fisher LD, Miller DR, Geller AC, et al
    Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527834. doi: 10.1093.
    PubMed     Abstract available


  141. HEININGER U
    Diphtheria, Tetanus, and Pertussis: Unequal Vaccine Siblings With Distinct Characteristics.
    Clin Infect Dis. 2022;74:562-563.
    PubMed    


  142. CONTOPOULOS-IOANNIDIS DG, Altamirano J, Maldonado Y
    Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010).
    Clin Infect Dis. 2022 Feb 9. pii: 6525447. doi: 10.1093.
    PubMed     Abstract available


  143. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
    Clin Infect Dis. 2022 Feb 9. pii: 6525466. doi: 10.1093.
    PubMed     Abstract available


  144. RISK M, Shen C, Hayek SS, Holevinski L, et al
    Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant.
    Clin Infect Dis. 2022 Feb 7. pii: 6523819. doi: 10.1093.
    PubMed     Abstract available


  145. DRAWZ PE, DeSilva M, Bodurtha P, Benitez GV, et al
    Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium.
    Clin Infect Dis. 2022 Feb 7. pii: 6523820. doi: 10.1093.
    PubMed     Abstract available


  146. PERNICIARO S, van der Linden M, Weinberger DM
    Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523816. doi: 10.1093.
    PubMed     Abstract available


  147. HELMSDAL G, Hansen OK, Moller LF, Christiansen DH, et al
    Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers.
    Clin Infect Dis. 2022 Feb 3. pii: 6520882. doi: 10.1093.
    PubMed     Abstract available


  148. ONG SWX, Sutjipto S, Lee PH, Dugan C, et al
    Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized COVID-19 patients in Singapore.
    Clin Infect Dis. 2022 Feb 3. pii: 6520952. doi: 10.1093.
    PubMed     Abstract available


  149. PISCHEL L, Patel KM, Goshua G, Omer SB, et al
    Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis.
    Clin Infect Dis. 2022 Feb 2. pii: 6520532. doi: 10.1093.
    PubMed     Abstract available


  150. NOUSHAD M, Al-Awar MS, Al-Saqqaf IS, Nassani MZ, et al
    Lack of access to COVID-19 vaccines could be a greater threat than vaccine hesitancy in low-income and conflict nations: the case of Yemen.
    Clin Infect Dis. 2022 Feb 2. pii: 6520556. doi: 10.1093.
    PubMed     Abstract available


  151. CROMER D, Reynaldi A, Steain M, Triccas JA, et al
    Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
    Clin Infect Dis. 2022 Feb 1. pii: 6518223. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  152. HOLMDAHL I, Kahn R, Slifka KJ, Dooling K, et al
    Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
    Clin Infect Dis. 2022 Jan 29. pii: 6517371. doi: 10.1093.
    PubMed     Abstract available


  153. WATKINS LKF, Mitruka K, Dorough L, Bressler SS, et al
    Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 -United States, January-April 2021.
    Clin Infect Dis. 2022 Jan 29. pii: 6517385. doi: 10.1093.
    PubMed     Abstract available


  154. MAERTENS K, Orije MRP, Herzog SA, Mahieu LM, et al
    Pertussis Immunization During Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm-Born Infants.
    Clin Infect Dis. 2022;74:189-198.
    PubMed     Abstract available


  155. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    PubMed    


  156. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515675. doi: 10.1093/cid/ciab1032.
    PubMed     Abstract available


  157. LAWRENZ J, Xie Q, Zech F, Weil T, et al
    SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.
    Clin Infect Dis. 2022 Jan 25. pii: 6515378. doi: 10.1093.
    PubMed     Abstract available


  158. LIU J, Laurie MT, Rubio L, Vazquez SE, et al
    SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
    Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
    PubMed     Abstract available


  159. MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
    Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
    PubMed     Abstract available


  160. SHRESTHA NK, Burke PC, Nowacki AS, Terpeluk P, et al
    Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.
    Clin Infect Dis. 2022 Jan 13. pii: 6507165. doi: 10.1093.
    PubMed     Abstract available


  161. OLSON SM, Newhams MM, Halasa NB, Feldstein LR, et al
    Vaccine Effectiveness Against Life-Threatening Influenza Illness in US Children.
    Clin Infect Dis. 2022 Jan 13. pii: 6506316. doi: 10.1093.
    PubMed     Abstract available


  162. HEFTDAL LD, Schultz M, Lange T, Knudsen AD, et al
    Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: Real life data from the Capital Region of Denmark.
    Clin Infect Dis. 2022 Jan 7. pii: 6500168. doi: 10.1093.
    PubMed     Abstract available


  163. LI X, Chan JM, Lam B, Lung DC, et al
    COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities.
    Clin Infect Dis. 2022 Jan 4. pii: 6497432. doi: 10.1093/cid/ciab1062.
    PubMed     Abstract available


    December 2021
  164. CHOW EPF, Fairley CK, Zou H, Wigan R, et al
    Human papillomavirus antibody levels following vaccination or natural infection among young men who have sex with men.
    Clin Infect Dis. 2021 Dec 31. pii: 6491220. doi: 10.1093/cid/ciab1052.
    PubMed     Abstract available


  165. LEWNARD JA, Bruxvoort KJ, Fischer H, Hong VX, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults.
    Clin Infect Dis. 2021 Dec 30. pii: 6490150. doi: 10.1093/cid/ciab1051.
    PubMed     Abstract available


  166. YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
    COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
    Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
    PubMed     Abstract available


  167. ESSINK B, Sabharwal C, Cannon K, Frenck R, et al
    Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults 18 Years and Older.
    Clin Infect Dis. 2021 Dec 23. pii: 6481672. doi: 10.1093.
    PubMed     Abstract available


  168. DAGAN R, Van Der Beek BA, Ben-Shimol S, Pilishvili T, et al
    Corrigendum to: Effectiveness of the 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media.
    Clin Infect Dis. 2021 Dec 21. pii: 6472232. doi: 10.1093.
    PubMed    


  169. SACHDEV DD, Chew Ng R, Sankaran M, Ernst A, et al
    Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients - San Francisco, California, January 29-July 2, 2021.
    Clin Infect Dis. 2021 Dec 20. pii: 6470866. doi: 10.1093/cid/ciab1042.
    PubMed     Abstract available


  170. TYNER HL, Burgess JL, Grant L, Gaglani M, et al
    Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Dec 20. pii: 6470720. doi: 10.1093/cid/ciab1038.
    PubMed     Abstract available


  171. LUO CH, Morris CP, Sachithanandham J, Amadi A, et al
    Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Clin Infect Dis. 2021 Dec 18. pii: 6469786. doi: 10.1093.
    PubMed     Abstract available


  172. LU L, Mok BW, Chen LL, Chan JM, et al
    Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
    Clin Infect Dis. 2021 Dec 16. pii: 6463504. doi: 10.1093/cid/ciab1041.
    PubMed     Abstract available


  173. DANINO D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, et al
    Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Clin Infect Dis. 2021 Dec 14. pii: 6460745. doi: 10.1093/cid/ciab1014.
    PubMed     Abstract available


  174. SAGARA I, Zongo I, Cairns M, Yerbanga RS, et al
    The Anti-Circumsporozoite Antibody Response Of Children To Seasonal Vaccination With The Rts,S/As01e Malaria Vaccine.
    Clin Infect Dis. 2021 Dec 11. pii: 6459764. doi: 10.1093/cid/ciab1017.
    PubMed     Abstract available


  175. BART SM, Harizaj A, Pearson CL, Conteh T, et al
    SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021.
    Clin Infect Dis. 2021 Dec 10. pii: 6459157. doi: 10.1093/cid/ciab1025.
    PubMed     Abstract available


  176. KHAN K, Lustig G, Bernstein M, Archary D, et al
    Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
    Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
    PubMed     Abstract available


  177. ROCCO JM, Mallarino-Haeger C, Randolph AH, Ray SM, et al
    Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation.
    Clin Infect Dis. 2021 Dec 10. pii: 6459155. doi: 10.1093/cid/ciab1024.
    PubMed     Abstract available


  178. FERNANDEZ-GONZALEZ M, Agullo V, Padilla S, Garcia JA, et al
    Clinical performance of a standardized SARS-CoV-2 interferon-gamma release assay for simple detection of T-cell responses after infection or vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6459152. doi: 10.1093/cid/ciab1021.
    PubMed     Abstract available


  179. HUANG YC, Sun HY, Sheng WH, Hsieh SM, et al
    Evolution of hepatitis B virus (HBV) serologic markers among antiretroviral-naive, young people living with HIV who had undergone neonatal HBV vaccination and initiated antiretroviral therapy.
    Clin Infect Dis. 2021 Dec 10. pii: 6459150. doi: 10.1093/cid/ciab1020.
    PubMed     Abstract available


  180. BUTT AA, Yan P, Shaikh OS, Mayr FB, et al
    Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population.
    Clin Infect Dis. 2021 Dec 10. pii: 6459161. doi: 10.1093/cid/ciab1023.
    PubMed     Abstract available


  181. TANG L, Cherry S, Tuomanen EI, Roubidoux EK, et al
    Host predictors of broadly cross-reactive antibodies against SARS-CoV-2 variants of concern differ between infection and vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6458694. doi: 10.1093.
    PubMed     Abstract available


  182. GANAIE F, Branche AR, Peasley M, Rosch JW, et al
    Oral streptococci expressing pneumococci-like cross-reactive capsule types can affect WHO recommended pneumococcal carriage procedure.
    Clin Infect Dis. 2021 Dec 10. pii: 6459029. doi: 10.1093/cid/ciab1003.
    PubMed     Abstract available


  183. LEWIS NM, Chung JR, Uyeki TM, Grohskopf L, et al
    Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines.
    Clin Infect Dis. 2021 Dec 7. pii: 6455504. doi: 10.1093/cid/ciab1016.
    PubMed     Abstract available


  184. HAN A, Czajkowski L, Rosas LA, Cervantes-Medina A, et al
    Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model.
    Clin Infect Dis. 2021;73:e4260-e4268.
    PubMed     Abstract available


  185. WANG W, Alvarado-Facundo E, Vassell R, Collins L, et al
    Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
    Clin Infect Dis. 2021;73:e4312-e4320.
    PubMed     Abstract available


  186. MCCONEGHY KW, Davidson HE, Canaday DH, Han L, et al
    Cluster-randomized Trial of Adjuvanted Versus Nonadjuvanted Trivalent Influenza Vaccine in 823 US Nursing Homes.
    Clin Infect Dis. 2021;73:e4237-e4243.
    PubMed     Abstract available


  187. SKOFF TH, Faulkner AE, Liang JL, Barnes M, et al
    Pertussis Infections Among Pregnant Women in the United States, 2012-2017.
    Clin Infect Dis. 2021;73:e3836-e3841.
    PubMed     Abstract available


  188. BOZIO CH, Blain A, Edge K, Farley MM, et al
    Clinical Characteristics and Adverse Clinical Outcomes of Invasive Haemophilus influenzae Serotype a Cases-United States, 2011-2015.
    Clin Infect Dis. 2021;73:e3670-e3676.
    PubMed     Abstract available


  189. USUF E, Bottomley C, Gladstone R, Bojang E, et al
    Persistent and Emerging Pneumococcal Carriage Serotypes in a Rural Gambian Community After 10 Years of Pneumococcal Conjugate Vaccine Pressure.
    Clin Infect Dis. 2021;73:e3825-e3835.
    PubMed     Abstract available


  190. PEPPA M, Thomas SL, Minassian C, Walker JL, et al
    Seasonal Influenza Vaccination During Pregnancy and the Risk of Major Congenital Malformations in Live-born Infants: A 2010-2016 Historical Cohort Study.
    Clin Infect Dis. 2021;73:e4296-e4304.
    PubMed     Abstract available


  191. REZAHOSSEINI O, Sorensen SS, Perch M, Ekenberg C, et al
    Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
    Clin Infect Dis. 2021;73:e3733-e3739.
    PubMed     Abstract available


  192. SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
    Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
    Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
    PubMed     Abstract available


  193. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2021 Dec 5. pii: 6453395. doi: 10.1093/cid/ciab1007.
    PubMed     Abstract available


  194. PANNUS P, Neven KY, De Craeye S, Heyndrickx L, et al
    Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naive residents of nursing homes.
    Clin Infect Dis. 2021 Dec 3. pii: 6448839. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  195. GRUNAU B, Asamoah-Boaheng M, Lavoie PM, Karim ME, et al
    A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
    Clin Infect Dis. 2021 Nov 30. pii: 6446287. doi: 10.1093.
    PubMed     Abstract available


  196. BELAY ED, Godfred Cato S, Rao AK, Abrams J, et al
    Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445178. doi: 10.1093.
    PubMed     Abstract available


  197. CHUA GT, Kwan MYW, Chui CSL, Smith RD, et al
    Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445179. doi: 10.1093.
    PubMed     Abstract available


  198. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration.
    Clin Infect Dis. 2021 Nov 27. pii: 6444809. doi: 10.1093.
    PubMed    


  199. CORREA H, Soslow JH, Dendy JM, Creech CB, et al
    Acute myopericarditis post intravenous injection of COVID-19 mRNA vaccine differs from viral myocarditis.
    Clin Infect Dis. 2021 Nov 26. pii: 6443709. doi: 10.1093.
    PubMed    


  200. LI C, Chen Y, Zhao Y, Christopher Lung D, et al
    Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
    Clin Infect Dis. 2021 Nov 25. pii: 6438764. doi: 10.1093.
    PubMed    


  201. GAZIT S, Mizrahi B, Kalkstein N, Neuberger A, et al
    BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients.
    Clin Infect Dis. 2021 Nov 24. pii: 6437962. doi: 10.1093.
    PubMed     Abstract available


  202. STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
    Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
    PubMed     Abstract available


  203. CANADAY DH, Oyebanji OA, Keresztesy D, Payne M, et al
    Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
    Clin Infect Dis. 2021 Nov 19. pii: 6432026. doi: 10.1093.
    PubMed     Abstract available


  204. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    PubMed     Abstract available


  205. POLLOCK L, Bennett A, Jere KC, Mandolo J, et al
    Plasma rotavirus-specific IgA and risk of rotavirus vaccine failure in infants in Malawi.
    Clin Infect Dis. 2021 Nov 12. pii: 6426173. doi: 10.1093.
    PubMed     Abstract available


  206. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    PubMed     Abstract available


  207. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    PubMed     Abstract available


  208. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    PubMed     Abstract available


  209. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    PubMed     Abstract available


  210. BRAMUGY J, Mucasse H, Massora S, Vitorino P, et al
    Short and long-term outcomes of GBS invasive disease in Mozambican children: Results of a case cohort and retrospective observational study and implications for future vaccine introduction.
    Clin Infect Dis. 2021 Nov 2. pii: 6388780. doi: 10.1093.
    PubMed     Abstract available


  211. MALVOLTI S, Pecenka C, Mantel C, Malhame M, et al
    A financial and global demand analysis to inform decisions for funding and clinical development of GBS vaccines for pregnant women.
    Clin Infect Dis. 2021 Nov 2. pii: 6412619. doi: 10.1093.
    PubMed     Abstract available


  212. BROWN NE, Blain AE, Burzlaff K, Harrison LH, et al
    Racial Disparities in Invasive Haemophilus influenzae Disease-United States, 2008-2017.
    Clin Infect Dis. 2021;73:1617-1624.
    PubMed     Abstract available


  213. BERENSON AB, Hirth JM, Chang M
    Prevalence of Genital Human Papillomavirus by Age and Race/Ethnicity Among Males.
    Clin Infect Dis. 2021;73:1625-1633.
    PubMed     Abstract available


  214. MIELLET WR, van Veldhuizen J, Nicolaie MA, Mariman R, et al
    Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults.
    Clin Infect Dis. 2021;73:e2680-e2689.
    PubMed     Abstract available


  215. THOMPSON RR, Kong CL, Porco TC, Kim E, et al
    Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States.
    Clin Infect Dis. 2021;73:e3210-e3217.
    PubMed     Abstract available


  216. ISHIKAWA T, Okai M, Mochizuki E, Uchiyama T, et al
    Bacillus Calmette-Guerin (BCG) Infections at High Frequency in Both AR-CGD and X-CGD Patients Following BCG Vaccination.
    Clin Infect Dis. 2021;73:e2538-e2544.
    PubMed     Abstract available


  217. TESSIER E, Campbell H, Ribeiro S, Fry NK, et al
    Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014-2018.
    Clin Infect Dis. 2021;73:e2502-e2508.
    PubMed     Abstract available


  218. LEE JH, Lee YB, Cho EJ, Yu SJ, et al
    Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
    Clin Infect Dis. 2021;73:e3308-e3316.
    PubMed     Abstract available


    October 2021
  219. MARSHALL GS, Ghaswalla PK, Bengtson LGS, Buikema AR, et al
    Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States.
    Clin Infect Dis. 2021 Oct 28. pii: 6413775. doi: 10.1093.
    PubMed     Abstract available


  220. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    PubMed     Abstract available


  221. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2021 Oct 26. pii: 6410706. doi: 10.1093.
    PubMed    


  222. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    PubMed     Abstract available


  223. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    PubMed     Abstract available


  224. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    PubMed     Abstract available


  225. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    PubMed     Abstract available


  226. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    PubMed     Abstract available


  227. ISTURIZ R, Grant L, Gray S, Alexander-Parrish R, et al
    Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.
    Clin Infect Dis. 2021;73:1216-1222.
    PubMed     Abstract available


  228. LADHANI SN, Campbell H, Andrews N, Parikh SR, et al
    First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England.
    Clin Infect Dis. 2021;73:e1661-e1668.
    PubMed     Abstract available


  229. MARSHALL HS, Maiden MCJ
    Impact of a Meningococcal Protein-based Serogroup B Vaccine on Serogroup W Invasive Disease in Children.
    Clin Infect Dis. 2021;73:e1669-e1672.
    PubMed    


  230. HUANG W, Chiu NC, Chi H, Huang FY, et al
    Inoculation Age of Bacillus Calmette-Guerin Tokyo-172 Strain and Vaccine-related Adverse Reactions in Taiwan Birth Cohort of 2012-2017.
    Clin Infect Dis. 2021;73:e1554-e1559.
    PubMed     Abstract available


  231. MARIN M, Fiebelkorn AP, Bi D, Coleman LA, et al
    Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.
    Clin Infect Dis. 2021;73:e1546-e1553.
    PubMed     Abstract available


  232. HURLEY D, Griffin C, Young M, Scott DA, et al
    Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age.
    Clin Infect Dis. 2021;73:e1489-e1497.
    PubMed     Abstract available


  233. RIVERA L, Biswal S, Saez-Llorens X, Reynales H, et al
    Three years efficacy and safety of Takeda's dengue vaccine candidate (TAK-003).
    Clin Infect Dis. 2021 Oct 4. pii: 6381105. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  234. LUNDBO LF, Harboe ZB, Sandholdt H, Smith-Hansen L, et al
    Comorbidity increases the risk of invasive meningococcal disease in adults.
    Clin Infect Dis. 2021 Sep 27. pii: 6375918. doi: 10.1093.
    PubMed     Abstract available


  235. MAZUR NI, Lowensteyn YN, Willemsen JE, Gill CJ, et al
    Global Respiratory Syncytial Virus-Related Infant Community Deaths.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  236. SRIKANTIAH P, Vora P, Klugman KP
    Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies.
    Clin Infect Dis. 2021;73.
    PubMed     Abstract available


  237. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  238. DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
    Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
    Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  239. KOELMAN DLH, Brouwer MC, Ter Horst L, Bijlsma MW, et al
    Pneumococcal meningitis in adults: a prospective nationwide cohort studY over a 20-year period.
    Clin Infect Dis. 2021 May 24. pii: 6283697. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  240. DEGRAZIA D, Miller FG
    SARS-CoV-2 Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.
    Clin Infect Dis. 2021 Mar 31. pii: 6205379. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  241. DAGAN R, Ben-Shimol S, Benisty R, Regev-Yochay G, et al
    A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus Pneumoniae Serotype 2.
    Clin Infect Dis. 2020 Nov 17. pii: 5983781. doi: 10.1093/cid/ciaa1720.
    PubMed     Abstract available


    September 2020
  242. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    PubMed     Abstract available


    July 2020
  243. HUANG H, Xu C, Liu L, Chen L, et al
    Increased protection of earlier use of immunoprophylaxis in preventing perinatal transmission of hepatitis B virus.
    Clin Infect Dis. 2020 Jul 8. pii: 5868509. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  244. KANSAGRA K, Parmar D, Mendiratta SK, Patel J, et al
    A Phase 3, Randomised, Open-Label, Non-inferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).
    Clin Infect Dis. 2020 Jun 17. pii: 5858415. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: